Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 23

Trial Status

Completed1
Other2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT04031872Phase 1/2Withdrawn
LY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615)
Colorectal Cancer Metastatic
PrincipalinvestigatorStart date: 2020-01-01
NCT03482362Phase 2Completed
Vinorelbine in Advanced BRAF-like Colon Cancer
Colon Cancer
PrincipalinvestigatorStart date: 2018-03-01
NCT03470350Phase 1/2Withdrawn
Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer
Colorectal Cancer Metastatic
Principalinvestigator

Research Network

Collaboration Network

12 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

ONCG

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

A Bardelli, Prof

UNITO

Moderately Similar
3 trials

Shared therapeutic areas:

Colorectal Cancer MetastaticCancer of Colon

Worked with same sponsors:

AgendiaAzienda Ospedaliera Niguarda Cà Granda+9 more
Collaborated on 3 trials
Similarity Score32%

R Salazar, MD, PhD

ICO

Moderately Similar
3 trials

Shared therapeutic areas:

Colorectal Cancer MetastaticCancer of Colon

Worked with same sponsors:

AgendiaAzienda Ospedaliera Niguarda Cà Granda+9 more
Collaborated on 3 trials
Similarity Score32%

S Tejpar, Prof

UZ Leuven

Moderately Similar
3 trials

Shared therapeutic areas:

Colorectal Cancer MetastaticCancer of Colon

Worked with same sponsors:

AgendiaAzienda Ospedaliera Niguarda Cà Granda+9 more
Collaborated on 3 trials
Similarity Score32%

J Tabernero, Prof

VHIO

Moderately Similar
3 trials

Shared therapeutic areas:

Colorectal Cancer MetastaticCancer of Colon

Worked with same sponsors:

AgendiaAzienda Ospedaliera Niguarda Cà Granda+9 more
Collaborated on 3 trials
Similarity Score32%

A Cervantes, Prof

Instituto de Investigacion Sanitaria INCLIVA

Moderately Similar
3 trials

Shared therapeutic areas:

Colorectal Cancer MetastaticCancer of Colon

Worked with same sponsors:

AgendiaAzienda Ospedaliera Niguarda Cà Granda+9 more
Collaborated on 3 trials
Similarity Score32%

Sabine Hazan, MD

ProgenaBiome

Moderately Similar
41 trials

Shared therapeutic areas:

Cancer of ColonColorectal Cancer Metastatic
Similarity Score30%

Yanhong Deng, M.D.

Sixth Affiliated Hospital, Sun Yat-sen University

Moderately Similar
8 trials

Shared therapeutic areas:

Cancer of ColonColorectal Cancer Metastatic
Similarity Score30%

Lillian Siu, MD

Princess Margaret Cancer Centre

Moderately Similar
12 trials

Shared therapeutic areas:

Cancer of ColonColorectal Cancer Metastatic
Similarity Score30%

Norman Wolmark, MD

NSABP Foundation Inc

Moderately Similar
54 trials

Shared therapeutic areas:

Cancer of ColonColorectal Cancer Metastatic

Worked with same sponsors:

Eli Lilly and Company
Similarity Score30%

R Bernards, Prof

Agendia

Related
2 trials

Shared therapeutic areas:

Cancer of ColonColorectal Cancer Metastatic

Worked with same sponsors:

AgendiaAzienda Ospedaliera Niguarda Cà Granda+9 more
Collaborated on 2 trials
Similarity Score28%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04031872Phase 1/2PrincipalInvestigator

LY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615)

Colorectal Cancer Metastatic
Withdrawn
NCT03482362Phase 2PrincipalInvestigator

Vinorelbine in Advanced BRAF-like Colon Cancer

Colon Cancer
Completed
NCT03470350Phase 1/2PrincipalInvestigator

Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer

Colorectal Cancer Metastatic
Withdrawn

All 3 trials loaded